4//SEC Filing
Nazak Michael Adrian 4
Accession 0000899243-23-005550
CIK 0001880438other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 7:23 PM ET
Size
5.3 KB
Accession
0000899243-23-005550
Insider Transaction Report
Form 4
Nazak Michael Adrian
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-15+16,600→ 16,600 totalExercise: $14.29Exp: 2033-02-14→ Common Stock (16,600 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as follows: 1/48 of the shares shall vest on each monthly anniversary as measured from January 1, 2023.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001799731
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 7:23 PM ET
- Size
- 5.3 KB